“The problem with the new one is it doesn’t have any distinctive characters,” Clarke said. “It’s no longer meaningful. It’s ...
The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback